Literature DB >> 10100611

A stable interaction between syntaxin 1a and synaptobrevin 2 mediated by their transmembrane domains.

M Margittai1, H Otto, R Jahn.   

Abstract

The proteins synaptobrevin (VAMP), SNAP-25 and syntaxin 1 are essential for neuronal exocytosis. They assemble into a stable ternary complex which is thought to initiate membrane fusion. In vitro, the transmembrane domains of syntaxin and synaptobrevin are not required for association. Here we report a novel interaction between synaptobrevin and syntaxin that requires the presence of the transmembrane domains. When co-reconstituted into liposomes, the proteins form a stable binary complex that cannot be disassembled by NSF and that is resistant to denaturation by SDS. Cleavage of synaptobrevin with tetanus toxin does not affect the interaction. Furthermore, the complex is formed when a truncated version of syntaxin is used that contains only 12 additional amino acid residues outside the membrane anchor. We conclude that the interaction is mediated by the transmembrane domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100611     DOI: 10.1016/s0014-5793(99)00028-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Three SNARE complexes cooperate to mediate membrane fusion.

Authors:  Y Hua; R H Scheller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

2.  Landscape of target:guide homology effects on Cas9-mediated cleavage.

Authors:  Becky Xu Hua Fu; Loren L Hansen; Karen L Artiles; Michael L Nonet; Andrew Z Fire
Journal:  Nucleic Acids Res       Date:  2014-11-15       Impact factor: 16.971

3.  Botulinum toxin type B micromechanosensor.

Authors:  W Liu; Vedrana Montana; Edwin R Chapman; U Mohideen; Vladimir Parpura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

4.  Determinants of liposome fusion mediated by synaptic SNARE proteins.

Authors:  Christina G Schuette; Kiyotaka Hatsuzawa; Martin Margittai; Alexander Stein; Dietmar Riedel; Petra Küster; Marcelle König; Claus Seidel; Reinhard Jahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

5.  De novo design of conformationally flexible transmembrane peptides driving membrane fusion.

Authors:  Mathias W Hofmann; Katrin Weise; Julian Ollesch; Prashant Agrawal; Holger Stalz; Walter Stelzer; Frans Hulsbergen; Huub de Groot; Klaus Gerwert; Jennifer Reed; Dieter Langosch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

6.  Synaptobrevin Transmembrane Domain Dimerization Studied by Multiscale Molecular Dynamics Simulations.

Authors:  Jing Han; Kristyna Pluhackova; Tsjerk A Wassenaar; Rainer A Böckmann
Journal:  Biophys J       Date:  2015-08-18       Impact factor: 4.033

7.  v-SNAREs control exocytosis of vesicles from priming to fusion.

Authors:  Maria Borisovska; Ying Zhao; Yaroslav Tsytsyura; Nataliya Glyvuk; Shigeo Takamori; Ulf Matti; Jens Rettig; Thomas Südhof; Dieter Bruns
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

8.  Determinants of synaptobrevin regulation in membranes.

Authors:  Tabrez J Siddiqui; Olga Vites; Alexander Stein; Rainer Heintzmann; Reinhard Jahn; Dirk Fasshauer
Journal:  Mol Biol Cell       Date:  2007-03-14       Impact factor: 4.138

9.  Sequence-specific conformational flexibility of SNARE transmembrane helices probed by hydrogen/deuterium exchange.

Authors:  Walter Stelzer; Bernhard C Poschner; Holger Stalz; Albert J Heck; Dieter Langosch
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

10.  PI(4,5)P2-dependent regulation of exocytosis by amisyn, the vertebrate-specific competitor of synaptobrevin 2.

Authors:  Ilona Kondratiuk; Shrutee Jakhanwal; Jialin Jin; Udhayabhaskar Sathyanarayanan; Benjamin Kroppen; Ajaybabu V Pobbati; Anita Krisko; Uri Ashery; Michael Meinecke; Reinhard Jahn; Dirk Fasshauer; Ira Milosevic
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.